LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 65.61 | 770.25 | 9203 | 9736 | 0.9453 | 0.9695 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 67.83 | 770.25 | 7924 | 10078 | 0.7862 | 0.8745 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 67.83 | 770.25 | 9528 | 10078 | 0.9454 | 0.9700 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.05 | 770.25 | 8092 | 10413 | 0.7771 | 0.8701 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.05 | 770.25 | 9905 | 10413 | 0.9512 | 0.9735 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.27 | 770.25 | 8205 | 10730 | 0.7646 | 0.8636 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 72.27 | 770.25 | 10120 | 10730 | 0.9431 | 0.9694 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.50 | 770.25 | 8280 | 10991 | 0.7533 | 0.8576 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.50 | 770.25 | 10387 | 10991 | 0.9450 | 0.9707 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.75 | 770.25 | 8235 | 11262 | 0.7312 | 0.8446 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.75 | 770.25 | 10593 | 11262 | 0.9405 | 0.9686 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.98 | 770.25 | 8283 | 11518 | 0.7191 | 0.8380 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.98 | 770.25 | 10980 | 11518 | 0.9533 | 0.9756 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.20 | 770.25 | 8449 | 11766 | 0.7181 | 0.8385 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.20 | 770.25 | 11131 | 11766 | 0.9460 | 0.9720 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 83.42 | 770.25 | 8482 | 12031 | 0.7050 | 0.8312 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 83.42 | 770.25 | 11392 | 12031 | 0.9468 | 0.9726 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 85.64 | 770.25 | 8441 | 12287 | 0.6870 | 0.8206 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 85.64 | 770.25 | 11720 | 12287 | 0.9538 | 0.9765 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 770.25 | 8504 | 12543 | 0.6780 | 0.8159 | MN20160304_L02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 770.25 | 11909 | 12543 | 0.9494 | 0.9744 | MN20160304_L02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.21 | 770.25 | 856 | 904 | 0.9463 | 0.5762 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.21 | 770.25 | 1002 | 904 | 1.1076 | 2.1075 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.44 | 770.25 | 940 | 1012 | 0.9282 | 0.6559 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.44 | 770.25 | 1107 | 1012 | 1.0931 | 1.5055 | MN20160304_L02 | J17 |